financetom
Business
financetom
/
Business
/
Nasdaq Seeks SEC Approval to Enable Trading of Tokenized Securities
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nasdaq Seeks SEC Approval to Enable Trading of Tokenized Securities
Sep 8, 2025 1:26 PM

04:12 PM EDT, 09/08/2025 (MT Newswires) -- Nasdaq (NDAQ) filed a proposal Monday with the US Securities and Exchange Commission to amend its rules to allow trading of securities in tokenized form.

The change would give investors the option of trading securities via traditional digital representation of ownership, with or without blockchain backing, according to the filing.

"The exchange believes the markets can use tokenization while continuing to provide the benefits and protections of the national market system," according to the filing.

Trading in tokenized securities may begin once the required infrastructure and post-trade settlement services are set up by the Depository Trust Co., possibly by the end of Q3 2026, Nasdaq said.

Price: 94.97, Change: +1.49, Percent Change: +1.59

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TFI International Q4 Adjusted Earnings Decline, Revenue Rises
TFI International Q4 Adjusted Earnings Decline, Revenue Rises
Feb 19, 2025
04:17 PM EST, 02/19/2025 (MT Newswires) -- TFI International ( TFII ) reported Q4 adjusted diluted earnings Wednesday of $1.19 per share, down from $1.71 a year earlier. Analysts polled by FactSet expected $1.57. Revenue for the quarter ended Dec. 31 was $2.08 billion, up from $1.97 billion a year earlier. Analysts surveyed by FactSet expected $2.18 billion. ...
BioMarin Pharmaceutical Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set -- Shares Up After Hours
BioMarin Pharmaceutical Q4 Non-GAAP Earnings, Revenue Rise; 2025 Outlook Set -- Shares Up After Hours
Feb 19, 2025
04:17 PM EST, 02/19/2025 (MT Newswires) -- BioMarin Pharmaceutical ( BMRN ) late Wednesday reported Q4 non-GAAP earnings of $0.92 per diluted share, compared with $0.49 a year earlier. Analysts polled by FactSet expected $0.74. Revenue for the quarter ended Dec. 31 was $747.3 million, compared with $646.2 million a year earlier. Analysts polled by FactSet expected $712.3 million. For...
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,279,661, According to a Recent SEC Filing
Teva Pharmaceutical Industries Insider Sold Shares Worth $1,279,661, According to a Recent SEC Filing
Feb 19, 2025
04:15 PM EST, 02/19/2025 (MT Newswires) -- Richard D Francis, President and CEO, on February 15, 2025, sold 75,506 shares in Teva Pharmaceutical Industries ( TEVA ) for $1,279,661. Following the Form 4 filing with the SEC, Francis has control over a total of 209,444 common shares of the company, with 209,444 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/818686/000095017025023126/xslF345X05/ownership.xml ...
Weave Communications Insider Sold Shares Worth $623,332, According to a Recent SEC Filing
Weave Communications Insider Sold Shares Worth $623,332, According to a Recent SEC Filing
Feb 19, 2025
04:15 PM EST, 02/19/2025 (MT Newswires) -- Erin Goodsell, Chief Legal Officer & Corporate Secretary, on February 14, 2025, sold 35,802 shares in Weave Communications ( WEAV ) for $623,332. Following the Form 4 filing with the SEC, Goodsell has control over a total of 557,872 common shares of the company, with 557,872 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1609151/000160915125000015/xslF345X05/wk-form4_1739998987.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved